Jackson Acquisition Company II
JACSJackson Acquisition Company II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more operating businesses.
Earnings
Next report
Date not yet announcedFinancials
Q1 2026Valuation & ratios
Competitors
By market cap
Profile
Jackson Acquisition Company II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more operating businesses. The company primarily focuses on identifying high-quality targets within the healthcare services and healthcare technology sectors, leveraging its management's expertise in multi-site healthcare operations and integration.
A newly formed blank check company competing with other SPACs and private equity firms for healthcare-related acquisition targets.
FAQ
- What is Jackson Acquisition Company II's market cap?
- Jackson Acquisition Company II (JACS) has a market capitalization of $319.3M and trades on NYSE.
- Who are Jackson Acquisition Company II's competitors?
- Jackson Acquisition Company II's key competitors include Range Capital Acquisition Corp II Class A Ordinary Shares, Harvard Ave Acquisition Corporation Class A Ordinary Share, GP-Act III Acquisition Corp. Class A Ordinary Share, and others. These companies compete in similar markets and product categories.
- Who does Jackson Acquisition Company II partner with?
- Jackson Acquisition Company II's notable partners include Roth Capital Partners, Continental Stock Transfer & Trust Company, New York Stock Exchange.
- Where is Jackson Acquisition Company II headquartered?
- Jackson Acquisition Company II is headquartered in United States of America. It has been publicly traded since 2025.